Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • weightbayou weightbayou Apr 7, 2010 8:02 PM Flag

    Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer

    Celldex is a $30 stock folks.

    A Study of CDX-1307, in Patients With Incurable Breast ...A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01)

    clinicaltrials.gov/ct2/show/NCT00709462 · Cached page

 
CLDX
26.76-0.99(-3.57%)Apr 17 4:00 PMEDT